Home > In process > Models of the human heart for biomedical research: Opportunities and challenges. > print

001     286086
005     20260413113805.0
024 7 _ |a 10.14814/phy2.70845
|2 doi
024 7 _ |a pmid:41954020
|2 pmid
024 7 _ |a pmc:PMC13062934
|2 pmc
037 _ _ |a DZNE-2026-00382
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Streckfuss-Bömeke, Katrin
|0 0000-0001-5137-7228
|b 0
245 _ _ |a Models of the human heart for biomedical research: Opportunities and challenges.
260 _ _ |a [Erscheinungsort nicht ermittelbar]
|c 2026
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1776073044_12975
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Model systems that mimic human cardiac structure and function are essential for the development of novel diagnostics and effective treatments for cardiovascular diseases. While non-human vertebrate models, from zebrafish to pig, remain vital to cardiovascular research, the translatability of findings to human patients is often limited. Therefore, animal experiments should be supplemented with human model systems, including human induced pluripotent stem cell-derived cells, 3D engineered constructs, and last but not least, native tissue preparations and isolated primary cardiomyocytes. However, while human myocardium remains the gold standard, human heart tissue - and particularly tissue from control hearts-remains scarce, and its use in research is generally restricted to settings where tissue has been excised from diseased or failing hearts. While it is in principle possible to use tissue from rejected non-failing donor hearts that cannot be transplanted, legal hurdles (e.g., in Germany) can restrict the use of non-transplanted donor organs in research. Given the challenges associated with accessing and using human tissue in biomedical research, an integrated strategy towards combining non-human vertebrate models, in silico models, and human tissue-derived models is recommended, enhancing the chances of successful research and development, and helping bridge the gap between preclinical and clinical research.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a animal models
|2 Other
650 _ 7 |a donor tissue
|2 Other
650 _ 7 |a human myocardium
|2 Other
650 _ 7 |a stem cell models
|2 Other
650 _ 7 |a vertebrate models
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Biomedical Research: methods
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Heart: physiology
|2 MeSH
650 _ 2 |a Myocytes, Cardiac
|2 MeSH
650 _ 2 |a Induced Pluripotent Stem Cells
|2 MeSH
700 1 _ |a Zelarayán, Laura C
|0 0000-0002-9001-0346
|b 1
700 1 _ |a Schnabel, Renate B
|0 0000-0001-7170-9509
|b 2
700 1 _ |a Kränkel, Nicolle
|0 0000-0002-9363-1770
|b 3
700 1 _ |a Maack, Christoph
|0 0000-0003-3694-4559
|b 4
700 1 _ |a Eschenhagen, Thomas
|0 0000-0003-1750-1170
|b 5
700 1 _ |a Kappler, Hannah E
|0 0000-0002-8615-6561
|b 6
700 1 _ |a Klingmüller, Ursula
|0 0000-0001-9845-3099
|b 7
700 1 _ |a Kramann, Rafael
|0 0000-0003-4048-6351
|b 8
700 1 _ |a Loewe, Axel
|0 0000-0002-2487-4744
|b 9
700 1 _ |a Milting, Hendrik
|0 0000-0001-9722-0007
|b 10
700 1 _ |a Molina, Cristina E
|0 0000-0003-3094-1568
|b 11
700 1 _ |a Panáková, Daniela
|0 0000-0002-8739-6225
|b 12
700 1 _ |a Podesser, Bruno K
|0 0000-0002-4641-7202
|b 13
700 1 _ |a Schnieke, Angelika
|0 0000-0002-5761-9635
|b 14
700 1 _ |a Schröder, Katrin
|0 0000-0002-3099-526X
|b 15
700 1 _ |a Seidel, Thomas
|0 0000-0002-3127-1693
|b 16
700 1 _ |a Sossalla, Samuel
|0 0000-0001-8034-2673
|b 17
700 1 _ |a Zgierski-Johnston, Callum
|0 0000-0002-6773-9884
|b 18
700 1 _ |a Zimmermann, Wolfram-Hubertus
|0 P:(DE-2719)9001434
|b 19
700 1 _ |a Rog-Zielinska, Eva A
|0 0000-0002-3295-4728
|b 20
700 1 _ |a Kohl, Peter
|0 0000-0003-0416-6270
|b 21
773 _ _ |a 10.14814/phy2.70845
|g Vol. 14, no. 7, p. e70845
|0 PERI:(DE-600)2724325-4
|n 7
|p e70845
|t Physiological reports
|v 14
|y 2026
|x 2051-817X
856 4 _ |u https://pub.dzne.de/record/286086/files/DZNE-2026-00382.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/286086/files/DZNE-2026-00382.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)9001434
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2026
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-05
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PHYSIOL REP : 2022
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-08-08T17:09:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-08-08T17:09:21Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2024-08-08T17:09:21Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-08-08T17:09:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-05
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-05
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-05
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-05
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21